Journal Review in Surgical Oncology: Neuroendocrine Tumors of the Small Bowel
Behind The Knife: The Surgery Podcast
Behind The Knife: The Surgery Podcast
4.8 • 1.4K Ratings
🗓️ 23 June 2025
⏱️ 31 minutes
🧾️ Download transcript
Summary
Hosts:
- Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center
- Daniel Nelson, DO, FACS (@usarmydoc24) is Surgical Oncologist/HPB surgeon at Kaiser LAMC in Los Angeles.
- Connor Chick, MD (@connor_chick) is a 2nd Year Surgical Oncology fellow at Ohio State University.
- Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a 1st Year Surgical Oncology fellow at MD Anderson.
- Beth (Elizabeth) Barbera, MD (@elizcarpenter16) is a PGY-6 General Surgery resident at Brooke Army Medical Center
Learning Objectives:
In this episode we review two important papers that discuss optimal management strategies of neuroendocrine tumors (NET) of the small bowel. The first paper by Singh and colleagues discusses the NETTER-2 trial investigating the role of radioligand therapy for NET as a first-line treatment. The second article by Maxwell et all challenges surgical dogma regarding optimal debulking cutoffs for debulking of NET.
Links to Papers Referenced in this Episode:
1. Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel M, Kunz PL, Chasen B, Tafuto S, Lastoria S, Capdevila J, García-Burillo A, Oh DY, Yoo C, Halfdanarson TR, Falk S, Folitar I, Zhang Y, Aimone P, de Herder WW, Ferone D; all the NETTER-2 Trial Investigators. [177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study. Lancet. 2024 Jun 29;403(10446):2807-2817. doi: 10.1016/S0140-6736(24)00701-3. Epub 2024 Jun 5. PMID: 38851203. https://pubmed.ncbi.nlm.nih.gov/38851203/
2. Maxwell JE, Sherman SK, O'Dorisio TM, Bellizzi AM, Howe JR. Liver-directed surgery of neuroendocrine metastases: What is the optimal strategy? Surgery. 2016 Jan;159(1):320-33. doi: 10.1016/j.surg.2015.05.040. Epub 2015 Oct 9. PMID: 26454679; PMCID: PMC4688152. https://pubmed.ncbi.nlm.nih.gov/26454679/
Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.
If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Behind the Night, the Surgery podcast, relevant and engaging content designed to help you Behind the Night. |
| 0:24.3 | This is Jason here. |
| 0:25.5 | If you're prepping for the complex general surgical oncology boards |
| 0:28.3 | or just looking to level up your surge oncology game, |
| 0:30.8 | you need to check out our surgical oncology board review. |
| 0:33.6 | This isn't some lame review with just flashcards and outlines. |
| 0:37.1 | We've created comprehensive high-yield scenarios covering the most tested diseases, |
| 0:41.8 | plus expert commentary, and updated guidelines that actually stick and are proven to help you pass the boards. |
| 0:47.5 | Breast, pancreas, sarcoma, you name it, we've got you covered. |
| 0:50.9 | Available on our app, so you can review anytime, anywhere. |
| 0:55.4 | Group discounts are available. Enjoy the episode and dominate the day. Hi, everyone, and welcome back to another journal |
| 1:01.4 | article review with your surgical oncology team. I'm Elizabeth Barbera. I'm a six-year resident |
| 1:06.5 | at Berkermanian Medical Center. I'm Connor Chick. I'm a surgical oncology fellow at Ohio State. |
| 1:11.7 | I'm Lexi Adams. I'm a surgical oncology fellow, M.D. Anderson. |
| 1:15.2 | I'm Tim Breland. I'm a surgical oncology staff of Brook Army Medical Center. |
| 1:19.4 | Unfortunately, Dr. Nelson couldn't make it this time around, but we're excited to have him |
| 1:23.7 | back for our next episode. |
| 1:25.4 | We're also thrilled to be signing on again with the BTK team for an additional two years |
| 1:30.1 | of great surgical oncology content. |
| 1:32.5 | So keep an ear out for new episodes with some new members as well. |
| 1:35.6 | Anyway, let's get started with today's episode, which we're all pretty excited about. |
| 1:39.5 | We highly recommend you guys check out our most recent clinical challenges episode, which was |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Behind The Knife: The Surgery Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Behind The Knife: The Surgery Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.